| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.00073 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.00082 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |